Shows
Thrombosis Awareness LibraryEpi 18 - The Challenges of Post‑Op VTESurgical procedures create a uniquely pro‑thrombotic environment. Virchow’s triad—venous stasis, endothelial injury, and hypercoagulability—describes the foundation of thrombus formation, and all three elements are markedly amplified during and after surgery. Together, these factors significantly raise the risk of developing deep vein thrombosis (DVT), which can progress into life‑threatening pulmonary embolism (PE).Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this e...
2026-03-1204 minThrombosis Awareness LibraryEpi 17 - Thrombosis in Myeloproliferative NeoplasmsThe classic Philadelphia-negative MPNs, which include Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are myeloproliferative disorders all characterized by clonal expansion of an abnormal hematopoietic stem/progenitor cell. This leads to excessive production of mature myeloid elements, such as an overabundance of red blood cells in PV or a marked increase in platelets in ET. Although biologically distinct, these disorders share a common predisposition to thrombosisWerfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool...
2026-02-1704 minThrombosis Awareness LibraryEpi 16 - Disseminated Intravascular CoagulationDisseminated Intravascular Coagulation is a life-threatening intravascular disorder characterized by endothelial injury, systemic activation of coagulation, and dysregulated fibrinolysis, leading to microvascular thrombosis and consumption of platelets and clotting factors. Importantly, Disseminated Intravascular Coagulation is not a primary disease but a complication of underlying conditions such as sepsis, trauma, malignancy, obstetric emergencies, or severe immune reactions. Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hop...
2026-01-1504 minThrombosis Awareness LibraryEpi 15 - Cold-Induced Vascular ChallengesThrombosis, Cardiovascular Risks, and Raynaud’s Phenomenon This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise the risk of thrombosis and vascular disorders, especially in individuals with pre-existing conditions. Winter is a critical period for vascular health. In fact, low temperatures trigger vasoconstriction, which, combined with increased platelet adhesion and reduced physical activity, heightens clot risk. The most strongly impacted pathology by cold-induced vasoconstriction is vascular disease. This deterioration occurs because constricted vessels raise blood pressure, slow circulation, limit tissue perf...
2026-01-0904 minThrombosis Awareness LibraryEpi 14 - Splanchnic Venous ThrombosisIn this episode, we highlight Splanchnic Venous Thrombosis, a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs. Splanchnic Venous Thrombosis represents a heterogeneous group of disorders affecting the portal, mesenteric, splenic, and hepatic veins. While commonly linked to liver cirrhosis and malignancy, Splanchnic Venous Thrombosis can also occur in non-cirrhotic, non-neoplastic patients. Its clinical relevance stems from complications such as intestinal ischemia, portal hypertension, and potential underlying systemic disorders, including malignancies, nephrotic syndrome, thrombophilia, or inflammatory diseases.Werfen is committed to Powering Patient Care and raising global a...
2026-01-0704 minThrombosis Awareness LibraryEpi 13 - Travel Tips and ThrombosisAlthough the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help minimize the risk while traveling.Listen for more informationWerfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!This episode includes AI-generated content.
2026-01-0503 minThrombosis Awareness LibraryEpi 12 - Thrombotic MicroangiopathiesThis issue focuses on thrombotic microangiopathies (TMAs)—a group of rare but life-threatening hematologic disorders.TMAs disrupt normal Hemostasis and often present with thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and organ dysfunction. Among these conditions, Thrombotic Thrombocytopenic Purpura (TTP) is one of the most studied and clinically significant subtypes due to its acute onset and high mortality if left untreated.Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool of the monthly articles of th...
2026-01-0204 minThrombosis Awareness LibraryEpi 11 - Cerebral Venous ThrombosisIn this new episode, we focus on Cerebral Venous Thrombosis (CVT), a rare yet serious condition involving blood clot formation in the brain’s venous system.Unlike arterial strokes, which involve arterial occlusion, CVT impacts the cerebral venous outflow, including dural sinuses and cortical veins. This condition accounts for 0.5-3% of all strokes and is more prevalent in younger adults, particularly women under 50, and patients with underlying prothrombotic conditions.Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a...
2025-12-2904 minThrombosis Awareness LibraryEpi 10 - Pulmonary Embolism and Chronic Obstructive Pulmonary DiseaseThis episode explores the relationship between two complex medical conditions—Pulmonary Embolism (PE) and Chronic Obstructive Pulmonary Disease (COPD)—which often present similar symptoms, making accurate diagnosis particularly difficult.PE and COPD are two critical respiratory conditions that frequently coexist, complicating diagnosis and treatment. PE involves the obstruction of pulmonary arteries by blood clots, usually originating from deep veins in the legs. COPD, a progressive lung disease, is characterized by airflow limitation and includes chronic bronchitis and emphysema.Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This libr...
2025-12-2204 minThrombosis Awareness LibraryEpi 09 - Obstetric Antiphospholipid SyndromeThis issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions...
2025-12-1904 minThrombosis Awareness LibraryEpi 08 - Catheter-related ThrombosisThis episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is expected to rise further.Central venous catheters (CVCs) are indispensable in modern medicine, especially for patients needing long-term intravenous therapy, chemotherapy, hemodialysis, or parenteral nutrition. Despite their benefits, CVCs can lead to several complications, with CRT being one of the most significant.Werfen is committed to Powering Patient Care and raising global awareness...
2025-12-1704 minThrombosis Awareness LibraryEpi 07 - Antiphospholipid SyndromeThis episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries, veins, or small vessels and/or spontaneous early miscarriages with maternal morbidity, caused by persistent antiphospholipid antibodies (aPL).The precise mechanisms by which aPLs lead to thrombosis are not fully understood. It is believed that these antibodies interfere with the normal function of phospholipids in the blood, essential for coagulation, leading to an increased risk of blood clot formation.
2025-12-1504 minThrombosis Awareness LibraryEpi 06 - May Thurner SyndromeIn this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is crucial, as DVT is often mistakenly seen as primarily affecting the elderly.May-Thurner Syndrome (MTS), also known as iliac vein compression syndrome or Cockett's syndrome, occurs when the right iliac artery compresses the left iliac vein, restricting blood flow and causing it to pool in the leg. This compression disrupts normal blood flow, leading to various complications, including DVT. While the prevalence of the disorder is unknown, this condition is found in 2–5% of patients und...
2025-12-1204 minThrombosis Awareness LibraryEpi 05 - Upper Extremity Deep Vein ThrombosisIn this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. Despite being less prevalent than lower extremity DVT, UEDVT presents notable health risks and warrants significant attention.Etiology and EpidemiologyUEDVT can arise from various factors. A common cause is the use of medical devices such as central venous catheters, pacemakers, or defibrillators, which can irritate or damage vein walls. Cancer and its treatments, particularly chemotherapy, can also elevate the risk. Additionally, repetitive arm...
2025-12-1004 minThrombosis Awareness LibraryEpi 04 - Understanding ThrombosisVTE is a leading cause of death and disability worldwide, affecting individuals of all ages, genders, and ethnicities. Often asymptomatic, misdiagnosed, and unrecognized at death, VTE poses a significant challenge for HCPs due to its insidiousness.Identifying and Managing Risk FactorsKey VTE risk factors include immobility, surgery, specific medical conditions, lifestyle choices, and family history. Recognizing at-risk patients is the first step in preventing thrombosis. HCPs should educate each patient on preventing clot formation and prescribe mechanical prophylaxis and anticoagulants for High-risk individuals.Werfen is...
2025-12-0804 minThrombosis Awareness LibraryEpi 03 - Unmasking Thrombophilia“Thrombophilia”, from the Greek words “trombo” (blood clot) and “philia” (affinity), indicates an increased tendency to form pathological intravascular thrombosis, which may develop spontaneously or at a young age. Screening is typically limited to high-risk individuals rather than the general population.In the early 1980s, both Protein C and Protein S deficiencies were identified in the United States. These autosomal dominant conditions increase thrombosis risk 5- to 10-fold in heterozygotes, while homozygosity is often fatal without treatment. In 1994, Prof. Bertina and his team discovered FV Leiden. This mutation, converting arginine 506 to glutamine, makes FV resistant to inactivation by activated protein C, s...
2025-12-0504 minThrombosis Awareness LibraryEpi 02 - History of ThrombosisThe history of thrombosis is intertwined with the evolution of medicine, which was once closely linked to philosophy. Aristotle made significant observations on blood coagulation, attributing it to the presence of fibrous material in the blood. Galen, a prominent Roman physician whose theories influenced Western medicine for over a millennium, was the first to introduce the term “thrombosis”, derived from the Greek word for curdling. Since then, thrombosis knowledge has evolved.Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using...
2025-12-0304 min
EEMEA Talks - HemostasisNew Frontiers - S4 Ep4 - Advances in HIT WorkflowWelcome to New Frontiers, the podcast where Hemostasis meets innovation. In this fourth episode, we spotlight Heparin-Induced Thrombocytopenia (HIT), a critical condition that demands swift diagnosis to prevent life-threatening complications. Together with Rossella Marcucci, Full Professor of Internal Medicine at the University of Florence and Director of the “Atherothrombotic Diseases” unit at Careggi University Hospital, we’ll discover the differences between Type I and Type II HIT, explore its pathophysiology, and highlight how automated testing can accelerate diagnosis, reduce uncertainty, and help clinicians avoid unnecessary treatment shifts. Join us in pushing boundaries and powering better patient care!
2025-11-2525 min
EEMEA Talks - HemostasisNew Frontiers - S4 Ep3 - Healthcare - Planning for CybersecurityWelcome to New Frontiers, the podcast where Hemostasis meets innovation. In this third episode, I’m joined once again by Dr. Marco Foracchia, Chief Information Officer at Azienda Unità Sanitaria Locale – IRCCS Reggio Emilia. Together, we’ll explore the critical topic of cybersecurity in healthcare, examining key regulatory frameworks, the role of risk assessments and contingency planning, and practical strategies for implementation. Tune in for an engaging conversation on how technology and preparedness are shaping the future of cybersecurity in this complex and evolving sector.
2025-11-1833 min
EEMEA Talks - HemostasisNew Frontiers - S4 Ep2 - Healthcare - An Increasing Target for CyberattacksWelcome to New Frontiers, the podcast where Hemostasis meets innovation. In this second episode, I’m joined by Dr. Marco Foracchia, Chief Information Officer at Azienda Unità Sanitaria Locale – IRCCS Reggio Emilia, for an insightful conversation on cybersecurity in healthcare. Together we’ll uncover why hospitals are prime targets for cyberattacks, the specific vulnerabilities they face, and how data protection compares across critical sectors. We’ll also break down common attack methods and practical strategies to prevent and respond to threats. Tune in to discover key insights and best practices for navigating today’s cybersecurity challenges in one of the most comple
2025-11-1131 min
EEMEA Talks - HemostasisNew Frontiers - S4 Ep1 - Bayesian QCWelcome to New Frontiers, the podcast where Hemostasis meets cutting-edge innovation. In our debut episode, we dive into the world of data with Dr. Panagiotis Tsiamyrtzis, a leading voice in Statistical Process Control and Bayesian methods, teaching at Politecnico di Milano and the Athens University of Economics and Business. Together, we’ll explore the strengths and limitations of Frequentist versus Bayesian approaches, and discover how Bayesian models—adaptive, self-starting, and powered by prior knowledge—can revolutionize Quality Control, especially when data is scarce. Tune in and find out how smart statistics are reshaping the future of Hemostasis.
2025-11-0458 minThrombosis Awareness LibraryEpi 01 - Thrombosis - A Silent KillerThrombosis: A Silent KillerThrombosis, the formation of a blood clot within a blood vessel, is a serious health condition that often goes unnoticed until it's too late. This silent killer can lead to devastating complications, including heart attacks, strokes, and pulmonary embolisms. Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. We hope you join this effort!This ep...
2025-10-3104 min
EEMEA Talks - HemostasisClot stories - S3 Ep4 - Meet NusaibaI’m Nusaiba, at 20 I had a two pulmonary embolism 10 months apart while studying at university. It was devastating and impacted every aspect of my life, I was completely unaware of how difficult recovery can be and did not know anything about some of the unexpected side effects of blood thinners. Four years down the line, I have had to adjust to a new normal where life involves a lot of hospital appointments! As a young person with a clot I had to navigate recovery while finishing my degree and now working full time, while also trying to enjoy life as...
2025-07-2241 min
EEMEA Talks - AutoimmunityS2 – Ep.6 – Dr. Conticini; Hope with Myositis: The Doctor’s PerspectiveEdoardo Conticini is an expert in rheumatological diseases, including vasculitis and idiopathic inflammatory myopathies. He carries out his freelance and research activities at the Rheumatology unit of the University Hospital of Siena. The work of those who diagnose autoimmune diseases, in this case myositis, is essential to be able to treat patients promptly, just as the psychological aspect is crucial to overcome the most acute moments. With Edoardo Conticini we also tackle research and new frontiers in a field of action that is still very unknown. Warning: we remind you that the content of this podcast does not in...
2025-07-0719 minEEMEA Talks - AutoimmunityS2 – Ep.5 – Brenda; Myositis and Me: How I Reclaimed My LifeBrenda is originally from South Africa but has lived in Siena for many years, where she has built a life with her husband and grown-up children. Her story is one of resilience — it begins with the onset of myositis, a condition that was difficult to diagnose at first. With the attentive care of medical professionals, she eventually found a path to recovery. Brenda’s testimony is a powerful account that captures both the darkness of illness and the gradual return to everyday life, surrounded by those she loves. Warning: we remind you that the content of this podcast does n...
2025-06-3010 min
EEMEA Talks - HemostasisClot stories - S3 Ep3 - Meet PriyaI’m Priyanka Sardana-Gakhar—friends call me Priya—a 29-year-old soccer player from Sydney, Australia. At 22, I earned a scholarship to play NCAA D1 in the U.S. and moved to Louisiana. My life took a sharp turn after a 14-hour flight back to cold Canberra, where I was diagnosed with multiple blood clots in my lungs. As an athlete, it’s easy to dismiss symptoms, and often, others do too. I’m sharing my story to make sure no one else goes through this, and to remind everyone to keep pushing for answers, no matter what.
2025-06-1941 minEEMEA Talks - AutoimmunityS2 – Ep.4 – Dr. Cavazzana; Understanding RA: A Doctor Breaks It DownIlaria Cavazzana is an expert in rheumatological diseases, including rheumatoid arthritis and its complications, and holds the role of Associate Professor of Rheumatology at the University of Brescia and Level I Medical Director at the UO Rheumatology and Clinical Immunology of the Spedali Civili, affiliated with the University of Brescia. With her we investigate new therapies, drugs and the use of artificial intelligence in the fight against rheumatoid arthritis.Warning: we remind you that the content of this podcast does not in any way replace the opinion of a doctor
2025-06-1626 minEEMEA Talks - AutoimmunityS2 – Ep.3 – Alessia; Rheumatoid Arthritis at 30: My Body, My FightAlessia is a mother of three children, studies communications, works in a shop. All this while fighting against rheumatoid arthritis, which in its most acute forms causes physical tiredness, pain, obvious and painful difficulties in dealing with daily life. Hers is a testimony of strength and tenacity and also of how to tell your first daughter what it means to live with an autoimmune disease. Alessia has an Instagram page, 'living with rheumatoid arthritis' and has made her story available to other patients. Warning: we remind you that the content of this podcast does not in any way...
2025-06-0923 minEEMEA Talks - AutoimmunityS2 – Ep.2 – Dr. Zingone; IBD Demystified: Clear Answers to Tough QuestionsFabiana Zingone is an expert in Gastrointestinal immune-mediated diseases, including chronic intestinal diseases and related complications. She is an associate professor of Gastroenterology at the Department of Surgery, Oncology and Gastroenterology at the University of Padua where she works. She tells Wetell about her daily commitment to research, new frontiers, and the importance of proper communication between doctor and patient.Warning: we remind you that the content of this podcast does not in any way replace the opinion of a doctor
2025-05-2620 minEEMEA Talks - AutoimmunityS2 – Ep.1 – Noemi: Life After the Bag: Living Fully with a StomaNoemi is a young woman who lives between Italy and the United Kingdom. Her story is that of someone who suddenly finds herself facing something unknown and painful, like Crohn's disease. Her life has changed, she has undergone surgery and lives with a stoma. Noemi has reacted, surrounded by her loved ones and today not only is she able to have a different quality of life, but she is active on social media to share her experience with other people who are on the same path as her.Warning: we remind you that the content of this podcast does not...
2025-05-1926 minEEMEA Talks - AutoimmunityEEMEA Talks - Autoimmunity Journeys Season 2 - Trailer🎙️ Welcome to EEMEA Talks, a Werfen podcast.In this new season, we once again shine a light on the hidden world of autoimmune diseases—through real stories, lived experiences,and voices that break the silence.Together with patients, doctors, and researchers,we explore how empathy, science, and personalized carecan make a real difference.Because every story matters.And stories can be a tool for powering patient care.
2025-05-1201 min
EEMEA Talks - HemostasisClot stories - S3 Ep2 - Meet LaineyLainey is a research technician for an Alzheimer's and Aging Laboratory. She graduated from Iowa State University with her bachelor’s degree in Animal Science. While at Iowa State, Lainey experienced two clotting events. Lainey is a proud, two time pulmonary embolism survivor. A latin proverb states,“by teaching, we learn”. Lainey uses this phrase to influence her personal life and her life spreading awareness around the risks, signs and symptoms of blood clots. When she isn’t in the laboratory, you can find Lainey with a camera in hand photographing pets and wildlife, or at home baking and crafting with her...
2025-04-2942 min
EEMEA Talks - HemostasisClot stories - S3 Ep1 - Meet EllieI’m Ellie Bradford, 24, from the UK. I had my first blood clot at just 16 years old due to May-Thurner Syndrome and the combined pill, and another unprovoked DVT at 24. Now on lifelong blood thinners, I want to raise awareness that blood clots can happen to anyone. Sharing my story is my way of helping others recognize the signs and push for the right diagnosis.
2025-03-2525 min
EEMEA Talks - AutoimmunityLupus S01E06 -You can live with itAndrea, a Brazilian woman living with lupus, shares her story about how she discovered her illness and, after a complex journey, found the ideal doctor and a lifestyle that allows her to live peacefully with lupus.
2024-10-1713 min
EEMEA Talks - AutoimmunityLupus S01E05 - About Lupus history and curiositiesIn Turin, Professor Savino Sciascia graciously welcomes us with excellent coffee as EEMEA Talks continues its exploration of autoimmune diseases, focusing specifically on lupus. Savino Sciascia is a full professor at the University of Turin and a researcher at CMID, the Center for Immunopathology and the Study of Rare Diseases.
2024-10-1015 min
EEMEA Talks - AutoimmunityLupus S01E04 - Lupus and new treatmentsThe early diagnosis of lupus and the psychological reactions of patients to this diagnosis represent a sensitive and critical period. Professor Pier Luigi Meroni, the Director of the Experimental Laboratory for Clinical Immunology and Rheumatology at the Auxologico Institute, is a leading authority in lupus research
2024-10-0315 min
EEMEA Talks - AutoimmunityCeliac Disease S01E03 - Family history and practical tipsThis new episode of EEMEA Talks aims to provide useful and practical tips with an interlocutor we met in the previous episode. Giulia Previtali is not only a doctor and researcher, but from the first seconds of this podcast, she reveals why her point of view is so important to us.
2024-09-1923 min
EEMEA Talks - AutoimmunityCeliac Disease S01E02 - Early diagnosis and patients’ reactionsEEMEA Talks is in Bergamo for a special interview. We don't want to reveal too much because Giulia Previtali's story is full of surprises and twists that we'll leave for you to discover by listening to this episode. What is certain is that the interview will be very useful. Happy listening!
2024-09-1211 min
EEMEA Talks - AutoimmunityCeliac Disease S01E01 - Experimental Therapies and Treatments Where We StandEEMEA Talks is in Naples to interview Professor Carolina Ciacci, Professor of Gastroenterology at the University of Salerno and Head of the Gastroenterology Unit. Carolina Ciacci is a reference point not only in the study of celiac disease but also in disseminating information about it through scientific magazines and on younger social networks such as TikTok.
2024-09-0511 min
EEMEA Talks - AutoimmunityEEMEA Talks - Autoimmunity Journeys - TrailerWe are happy to announce the new series of EEMEA Talks titled "Autoimmunity Journeys".The podcast consists of the parts of 3 episodes each, first part on Celiac Disease and the second on Lupus.Stay tuned for content covering laboratory medicine and scientific research, mixing current events, knowledge, and expertise. This is a testimony of Werfen's continuous contribution to Powering Patient Care.
2024-06-1801 min
EEMEA Talks - HemostasisWomen and Bleeding Disorders S02E04 - Management of Bleeding Disorders in WomenBleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the final episode of our podcast series on Women and Bleeding Disorders, we close our discussion with Dr. Lucia Rugeri, a specialist in clinical hemostasis, discussing the challenges of the management of bleeding disorders with special attention to challenges faced in the management of women-specific conditions. We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
2023-04-2611 min
EEMEA Talks - HemostasisWomen and Bleeding Disorders S02E03 - Patient Access, Education, and Diagnosis of Bleeding DisordersBleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the third episode of our podcast series on Women and Bleeding Disorders, we continue exploring with Dr. Lucia Rugeri, a specialist in clinical hemostasis, what is the situation of Patient Access to care, the state of the Education of patients and healthcare professionals on the topic, and how to Diagnose Bleeding Disorders with a special focus on women.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
2023-04-1909 min
EEMEA Talks - HemostasisWomen and Bleeding Disorders S02E02 - Women and girls with bleeding disorders: What are the numbers?Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. The second episode of our podcast series on Women and Bleeding Disorders is an interview with Dr. Lucia Rugeri, a specialist in clinical hemostasis, who has dedicated her career to caring for women with bleeding and thrombotic disorders who will share with us the situation in terms of numbers of bleeding disorders with a special focus on women.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays.
2023-04-1210 min
EEMEA Talks - HemostasisWomen and Bleeding Disorders S02E01 - Journey of a Patient with a Bleeding DisorderBleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. We are happy to introduce you to our podcast series on Women and Bleeding Disorders. Our first episode is an interview with Naja Skow Rasmussen to share her personal story as a patient dealing with a bleeding disorder and her journey of advocacy to find effective solutions for all patients who suffer from bleeding disorders.We continue to ask everyone to #EmbraceEquity and ensure that nobody, regardless of their gender, faces unnecessary #DiagnosticDelays
2023-04-0539 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E06 - The Invention of CoagulometersEpisode 6: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. Automated instruments have revolutionized the way Labs and Lab technicians deliver results and we will be sharing the backstage of the launch of the first automated analyzer for coagulation. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-10-1217 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E05 - The Impact of Chromogenic TestingEpisode 5: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. One type of assays for hemostasis is Chromogenic assays and in this episode, we will review the impact these assays have had. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-09-1411 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E04 - The History of HeparinEpisode 4: In the history of Hemostasis, the impact of Heparin in all its formats (unfractionated or low molecular weight) has had a significant impact as an anticoagulant for the management of thrombophilic and thrombotic conditions and the history of how it started to where we are today is worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-07-1321 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E03 - The Discovery of VWF and ADAMTS13Episode 3: In the history of Hemostasis, the discovery of Von Willebrand Factor and its cleaving protease ADAMTS13 has expanded our understanding of primary hemostasis and the bleeding and thrombotic disorders associated with defects of either component of this axis. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-06-1518 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E02 - The Evolution of D-DimerEpisode 2:In the history of Hemostasis, D-Dimer has evolved from a marker of fibrinolysis to several clinical use cases to help guide the diagnosis and the management of patients suspected of Venous Thromboembolism, disseminated intravascular coagulation, or guide anticoagulation therapy. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-05-1129 min
EEMEA Talks - HemostasisHistory of Hemostasis S01E01 - The History of WarfarinEpisode 1: In the history of Hemostasis, the impact of Warfarin on patient outcomes for the prevention of blood clots is immeasurable and the way this drug became a mainstay of anticoagulation therapy is quite a unique journey worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.
2022-04-0618 min